OR56B2P

Across TCGA pan-cancer cohorts, OR56B2P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR56B2P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR56B2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR56B2P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

UCS, DLBC, and ESCA are the cancer types where OR56B2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
DLBC	OS	Tertile	All	0.415	0.902	<.001	36	view →
ESCA	DFS	Tertile	II,III,IV	0.576	0.268	.014	24	view →
BRCA	DFS	Tertile	All	0.984	0.944	.017	21	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
COAD	OS	Tertile	III,IV	0.159	0.692	.021	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRC	DFS	Tertile	IV	0.127	0.405	.002	18	view →
THYM	DFS	Tertile	All	0.176	0.750	<.001	15	view →
LGG	OS	Tertile	All	0.969	0.865	.005	12	view →
OV	OS	Tertile	IV	0.855	0.349	.048	6	view →
SARC	OS	Tertile	All	0.703	0.865	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR56B2P–UCS (DFS)

Open the UCS breakdown →